Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples